Pharmaceuticals, Biotechnology and Life Sciences
TOKYO–(BUSINESS WIRE)–Kyowa Kirin Asia Pacific Pte. Ltd. (President: Chikakuni Kotani, Kyowa Kirin Asia Pacific), a wholly owned subsidiary of Kyowa…
REINACH, Switzerland–(BUSINESS WIRE)–Evolva (SIX:EVE) today announced the receipt of a letter from the US Environmental Protection Agency (EPA) shortly ahead of…
Cambridge Based Vaccine Company ImmBio has entered a licensing agreement with the largest vaccine producer in China, CNBG to Co-Develop…
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced…
AUGUSTUS is the largest trial in this high-risk patient population requiring both anticoagulant and antiplatelet therapies PRINCETON, N.J. & NEW…
Exploratory analyses of ARIEL3 Rubraca data in recurrent ovarian cancer presented in oral plenary and poster sessions Maintenance treatment with…
TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective…
–(BUSINESS WIRE)–Incyte is a global biopharmaceutical company focused on the discovery, development and commercialization of novel medicines to meet serious…
DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Management Systems Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to…
TORONTO–(BUSINESS WIRE)–Enigma Biomedical Group (EBG) today announced an exclusive license agreement with Merck, known as MSD outside the US and…